Drug Evaluation Committee Briefing on "Guidelines for Providing Information on Clinical Trials for Patients and the General Public, 3rd Edition" (held on 12/14/2023)

Jan 23, 2024

The following is the presentation material of the "Guideline for Provision of Information on Clinical Trials for Patients and the General Public Version 3" (held on December 14, 2023) held by the Drug Evaluation Committee of the Japan Pharmaceutical Manufacturers Association (JPMA).

Briefing on "Guideline for Provision of Information on Clinical Trials for Patients and the Public (Version 3)" (2.9MB)

Return to Drug Evaluation Committee Symposium Top

TOP